Dopamine	O
stimulates	O
expression	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
via	O
NF-kappaB	B-protein
in	O
cells	O
of	O
the	O
immune	O
system	O
.	O

Recent	O
studies	O
have	O
reported	O
that	O
lymphocytes	B-cell_type
produce	O
,	O
transport	O
and	O
bind	O
dopamine	O
present	O
in	O
plasma	O
.	O

However	O
,	O
the	O
action	O
of	O
dopamine	O
on	O
HIV-1	O
gene	O
expression	O
in	O
cells	O
of	O
the	O
immune	O
system	O
has	O
not	O
yet	O
been	O
examined	O
.	O

Here	O
,	O
we	O
have	O
investigated	O
the	O
regulation	O
of	O
HIV-1	O
expression	O
by	O
dopamine	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
and	O
in	O
primary	B-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
(	O
PBMC	B-cell_type
)	O
.	O

HIV-1	O
replication	O
was	O
increased	O
by	O
dopamine	O
,	O
which	O
correlated	O
with	O
the	O
increased	O
levels	O
of	O
HIV-1	O
transactivation	O
.	O

Our	O
transient	O
expression	O
data	O
revealed	O
that	O
dopamine	O
stimulated	O
transcription	O
through	O
the	O
NF-kappaB	B-DNA
element	I-DNA
present	O
in	O
the	O
long	B-DNA
terminal	I-DNA
repeat	I-DNA
.	O

The	O
importance	O
of	O
NF-kappaB	B-DNA
sites	I-DNA
was	O
confirmed	O
by	O
using	O
vectors	O
containing	O
wild-type	B-DNA
or	I-DNA
mutant	I-DNA
kappaB	I-DNA
sites	I-DNA
in	O
a	O
heterologous	B-DNA
promoter	I-DNA
.	O

Consistent	O
with	O
the	O
role	O
of	O
NF-kappaB	B-protein
in	O
mediating	O
dopamine	O
responsiveness	O
,	O
the	O
proteasome	O
inhibitor	O
MG132	O
abolished	O
dopamine-induced	O
transcriptional	O
activation	O
.	O

We	O
further	O
explored	O
the	O
effect	O
of	O
dopamine	O
in	O
the	O
presence	O
of	O
phorbol	O
esters	O
or	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
known	O
to	O
activate	O
NF-kappaB	B-protein
.	O

The	O
combination	O
of	O
dopamine	O
and	O
TNF-alpha	B-protein
led	O
to	O
a	O
stimulation	O
of	O
HIV-1	O
transcription	O
and	O
replication	O
.	O

However	O
,	O
in	O
contrast	O
with	O
TNF-alpha	B-protein
,	O
dopamine	O
treatment	O
did	O
not	O
affect	O
NF-kappaB	B-protein
DNA	O
binding	O
activity	O
nor	O
the	O
concentrations	O
of	O
p50	B-protein
,	O
p65	B-protein
and	O
IkappaB-alpha	B-protein
proteins	I-protein
,	O
which	O
suggests	O
a	O
distinct	O
NF-kappaB	B-protein
activation	O
mechanism	O
.	O

These	O
results	O
reveal	O
a	O
new	O
link	O
between	O
the	O
dopamine	O
system	O
,	O
cytokine	B-protein
signaling	O
pathway	O
and	O
regulation	O
of	O
gene	O
expression	O
via	O
the	O
involvement	O
of	O
NF-kappaB	B-protein
in	O
T	B-cell_type
cells	I-cell_type
and	O
PBMC	B-cell_type
.	O

©	NULL
1999	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
3291-3299	NULL
Dopamine	NULL
stimulates	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
via	NULL
NF-	NULL
<	NULL
B	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
Olivier	NULL
Rohr	NULL
,	NULL
Bassel	NULL
E.	NULL
Sawaya	NULL
'	NULL
``	NULL
,	NULL
Dominique	NULL
Lecestre	NULL
'	NULL
,	NULL
Dominique	NULL
Aunis	NULL
'	NULL
and	NULL
Evelyne	NULL
Schaeffer'*	NULL
Unité	NULL
338	NULL
INSERM	NULL
,	NULL
5	NULL
rue	NULL
Blaise	NULL
Pascal	NULL
,	NULL
67084	NULL
Strasbourg	NULL
Cedex	NULL
,	NULL
France	NULL
and	NULL
``	NULL
Center	NULL
for	NULL
NeuroVirology	NULL
and	NULL
Oncology	NULL
,	NULL
Allegheny	NULL
University	NULL
of	NULL
the	NULL
Health	NULL
Sciences	NULL
245N	NULL
15th	NULL
Street	NULL
,	NULL
Mailstop	NULL
406	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19102	NULL
,	NULL
USA	NULL
Received	NULL
May	NULL
6	NULL
,	NULL
1999	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
July	NULL
2	NULL
,	NULL
1999	NULL
ABSTRACT	NULL
Recent	NULL
studies	NULL
have	NULL
reported	NULL
that	NULL
Iymphocytes	NULL
pro-duce	NULL
,	NULL
transport	NULL
and	NULL
bind	NULL
dopamine	NULL
present	NULL
in	NULL
plasma	NULL
.	NULL

However	NULL
,	NULL
the	NULL
action	NULL
of	NULL
dopamine	NULL
on	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
examined	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
expression	NULL
by	NULL
dopamine	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
primary	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
.	NULL

HIV-1	NULL
replication	NULL
was	NULL
increased	NULL
by	NULL
dopamine	NULL
,	NULL
which	NULL
correlated	NULL
with	NULL
the	NULL
increased	NULL
levels	NULL
of	NULL
HIV-1	NULL
transactivation	NULL
.	NULL

Our	NULL
transient	NULL
expression	NULL
data	NULL
revealed	NULL
that	NULL
dopamine	NULL
stimulated	NULL
transcription	NULL
through	NULL
the	NULL
NF-xB	NULL
element	NULL
present	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
NF-xB	NULL
sites	NULL
was	NULL
confirmed	NULL
by	NULL
using	NULL
vectors	NULL
containing	NULL
wild-type	NULL
or	NULL
mutant	NULL
xB	NULL
sites	NULL
in	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
role	NULL
of	NULL
NF-xB	NULL
in	NULL
mediating	NULL
dopamine	NULL
responsiveness	NULL
,	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
abolished	NULL
dopamine-induced	NULL
transcriptional	NULL
activation	NULL
.	NULL

We	NULL
further	NULL
explored	NULL
the	NULL
effect	NULL
of	NULL
dopamine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phorbol	NULL
esters	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-q	NULL
)	NULL
known	NULL
to	NULL
activate	NULL
NF-xB	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
dopamine	NULL
and	NULL
TNF-a	NULL
led	NULL
to	NULL
a	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
transcription	NULL
and	NULL
replication	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
with	NULL
TNF-a	NULL
,	NULL
dopamine	NULL
treatment	NULL
did	NULL
not	NULL
affect	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
activity	NULL
nor	NULL
the	NULL
concentrations	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
IkB-a	NULL
proteins	NULL
,	NULL
which	NULL
suggests	NULL
a	NULL
distinct	NULL
NF-xB	NULL
activation	NULL
mechanism	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
a	NULL
new	NULL
link	NULL
between	NULL
the	NULL
dopamine	NULL
system	NULL
,	NULL
cytokine	NULL
signaling	NULL
pathway	NULL
and	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
via	NULL
the	NULL
involvement	NULL
of	NULL
NF-xB	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
PBMC	NULL
.	NULL

INTRODUCTION	NULL
Knowledge	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
which	NULL
govern	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
genome	NULL
is	NULL
essential	NULL
to	NULL
understand	NULL
the	NULL
persistent	NULL
viral	NULL
replication	NULL
and	NULL
viral	NULL
latency	NULL
underlying	NULL
HIV-l-associated	NULL
pathogenesis	NULL
.	NULL

HIV-1	NULL
transcription	NULL
is	NULL
directed	NULL
by	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
through	NULL
interactions	NULL
with	NULL
a	NULL
number	NULL
of	NULL
viral	NULL
and	NULL
host	NULL
cell	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
the	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
NF-KB	NULL
(	NULL
reviewed	NULL
in	NULL
1,2	NULL
)	NULL
.	NULL

Viral	NULL
production	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
which	NULL
mediate	NULL
their	NULL
action	NULL
through	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

Interleukin	NULL
6	NULL
affects	NULL
viral	NULL
expression	NULL
through	NULL
the	NULL
transcription	NULL
factor	NULL
NF-IL6	NULL
(	NULL
3	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
(	NULL
TNF-	NULL
)	NULL
,	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
(	NULL
4	NULL
)	NULL
,	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
5	NULL
)	NULL
,	NULL
phosphatidylcholine	NULL
hydrolysis	NULL
(	NULL
6	NULL
)	NULL
,	NULL
transforming	NULL
growth	NULL
factor-	NULL
}	NULL
(	NULL
TGF-B	NULL
)	NULL
(	NULL
7	NULL
)	NULL
and	NULL
amino	NULL
acid	NULL
analogs	NULL
(	NULL
8	NULL
)	NULL
stimulate	NULL
HIV-1	NULL
transcription	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Upon	NULL
stimulation-induced	NULL
nuclear	NULL
translocation	NULL
,	NULL
NF-KB	NULL
proteins	NULL
activate	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
through	NULL
binding	NULL
to	NULL
the	NULL
xB	NULL
enhancer	NULL
motif	NULL
located	NULL
in	NULL
the	NULL
-109/-79	NULL
LTR	NULL
region	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
recently	NULL
that	NULL
the	NULL
neuromodulator	NULL
dopamine	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
neuronal	NULL
cells	NULL
,	NULL
via	NULL
the	NULL
transcription	NULL
factor	NULL
COUP-TF	NULL
,	NULL
acting	NULL
on	NULL
the	NULL
proximal	NULL
-68/+80	NULL
LTR	NULL
region	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
dopamine	NULL
system	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
motor	NULL
,	NULL
cognitive	NULL
and	NULL
neuroendocrine	NULL
processes	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
.	NULL

Dopamine	NULL
mediates	NULL
its	NULL
effects	NULL
by	NULL
activating	NULL
second	NULL
messengers	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
G-protein-coupled	NULL
dopamine	NULL
receptors	NULL
.	NULL

The	NULL
action	NULL
of	NULL
dopamine	NULL
on	NULL
target	NULL
cells	NULL
affects	NULL
multiple	NULL
intracellular	NULL
pathways	NULL
,	NULL
such	NULL
as	NULL
formation	NULL
of	NULL
cyclic	NULL
AMP	NULL
,	NULL
inositolphosphates	NULL
and	NULL
arachidonic	NULL
acid	NULL
,	NULL
and	NULL
modulates	NULL
cellular	NULL
electrical	NULL
activity	NULL
by	NULL
altering	NULL
the	NULL
properties	NULL
of	NULL
ion	NULL
channels	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Pathways	NULL
to	NULL
the	NULL
nucleus	NULL
may	NULL
involve	NULL
adenyl	NULL
cyclase	NULL
and	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
or	NULL
Ca	NULL
#	NULL
+	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
or	NULL
tyrosine	NULL
kinase	NULL
proteins	NULL
,	NULL
which	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
CREB	NULL
,	NULL
AP-1	NULL
and	NULL
COUP-TF	NULL
through	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
events	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
cell	NULL
surface	NULL
receptor	NULL
binding	NULL
,	NULL
dopamine	NULL
is	NULL
also	NULL
transported	NULL
in	NULL
cells	NULL
via	NULL
specific	NULL
uptake	NULL
mechanisms	NULL
(	NULL
reviewed	NULL
in	NULL
16	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
lymphocytes	NULL
are	NULL
also	NULL
able	NULL
to	NULL
actively	NULL
produce	NULL
and	NULL
transport	NULL
catecholamines	NULL
,	NULL
such	NULL
as	NULL
dopamine	NULL
(	NULL
17,18	NULL
)	NULL
.	NULL

Dopamine	NULL
is	NULL
able	NULL
to	NULL
modulate	NULL
peripheral	NULL
blood	NULL
lymphocyte	NULL
activity	NULL
via	NULL
dopamine	NULL
D3	NULL
and	NULL
D5	NULL
receptors	NULL
(	NULL
19,20	NULL
)	NULL
.	NULL

However	NULL
,	NULL
effects	NULL
of	NULL
dopamine	NULL
on	NULL
HIV-1	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
have	NULL
not	NULL
been	NULL
examined	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
expression	NULL
by	NULL
the	NULL
neuromodulator	NULL
dopamine	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
in	NULL
human	NULL
primary	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
*To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
:	NULL
+33	NULL
388	NULL
45	NULL
67	NULL
18	NULL
;	NULL
Fax	NULL
:	NULL
+33	NULL
388	NULL
60	NULL
08	NULL
06	NULL
;	NULL
Email	NULL
:	NULL
schaeffer	NULL
@	NULL
neurochem.u-strasbg.fr	NULL
3292	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
(	NULL
PBMC	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
reveal	NULL
that	NULL
dopamine	NULL
is	NULL
able	NULL
to	NULL
stimulate	NULL
viral	NULL
replication	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
PBMC	NULL
.	NULL

This	NULL
correlates	NULL
with	NULL
increased	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
through	NULL
the	NULL
NF-KB	NULL
element	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
dopamine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phorbol	NULL
esters	NULL
and	NULL
TNF-	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
mechanism	NULL
of	NULL
dopamine-mediated	NULL
stimulation	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
classic	NULL
NF-KB	NULL
activation	NULL
mechanism	NULL
involving	NULL
signal-induced	NULL
NF-KB	NULL
nuclear	NULL
translocation	NULL
,	NULL
and	NULL
presents	NULL
similarities	NULL
with	NULL
the	NULL
recently	NULL
reported	NULL
TGF-fB-mediated	NULL
HIV-1	NULL
activation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
Cell	NULL
culture	NULL
media	NULL
and	NULL
all	NULL
reagents	NULL
,	NULL
unless	NULL
specified	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
.	NULL

[	NULL
``	NULL
CJchloramphenicol	NULL
was	NULL
obtained	NULL
from	NULL
NEN	NULL
Life	NULL
Science	NULL
.	NULL

Plasmid	NULL
constructs	NULL
The	NULL
LTR	NULL
(	NULL
LAI	NULL
)	NULL
-CAT	NULL
and	NULL
LTR	NULL
(	NULL
HXB2	NULL
)	NULL
Luc	NULL
vectors	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
12,21	NULL
)	NULL
.	NULL

LTR	NULL
(	NULL
HXB2	NULL
)	NULL
AGC-CAT	NULL
,	NULL
LTR	NULL
(	NULL
HX-B2	NULL
)	NULL
AxB-CAT	NULL
,	NULL
LTR	NULL
(	NULL
HXB2	NULL
)	NULL
ArB/GC-CAT	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
vector	NULL
was	NULL
constructed	NULL
by	NULL
isolating	NULL
the	NULL
Earl-HindlIII	NULL
LTR	NULL
insert	NULL
from	NULL
LTR	NULL
(	NULL
HXB2	NULL
)	NULL
AxB/GC-CAT	NULL
and	NULL
subcloning	NULL
the	NULL
blunt-ended	NULL
fragment	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pUC19-CATO	NULL
.	NULL

The	NULL
GC-WAP-CAT	NULL
,	NULL
GCmut-WAP-CAT	NULL
,	NULL
<	NULL
B-WAP-CAT	NULL
,	NULL
xBmut-WAP-CAT	NULL
vectors	NULL
contain	NULL
respectively	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
(	NULL
-79/-45	NULL
)	NULL
GC-rich	NULL
or	NULL
(	NULL
-104/-79	NULL
)	NULL
NF-KB	NULL
region	NULL
from	NULL
HIV-1	NULL
LTR	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
,	NULL
isolation	NULL
and	NULL
propagation	NULL
of	NULL
PBMC	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
and	NULL
penicillin/strepto-mycin	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
.	NULL

Human	NULL
PBMC	NULL
were	NULL
separated	NULL
from	NULL
whole	NULL
blood	NULL
collected	NULL
from	NULL
HIV	NULL
seronegative	NULL
donors	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
washed	NULL
thoroughly	NULL
to	NULL
remove	NULL
contaminating	NULL
platelets	NULL
and	NULL
cryopreserved	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin/ml	NULL
and	NULL
100	NULL
ug	NULL
of	NULL
streptomycin/ml	NULL
.	NULL

Cells	NULL
were	NULL
activated	NULL
with	NULL
2	NULL
ug/ml	NULL
phytohemaglutinin	NULL
and	NULL
20	NULL
U/ml	NULL
interleukin-2	NULL
for	NULL
2-3	NULL
days	NULL
before	NULL
HIV	NULL
infection	NULL
.	NULL

Transfections	NULL
,	NULL
CAT	NULL
and	NULL
luciferase	NULL
assays	NULL
Cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
with	NULL
1	NULL
pmol	NULL
of	NULL
reporter	NULL
plasmid	NULL
and	NULL
0.5	NULL
pmol	NULL
of	NULL
expression	NULL
vector	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
1	NULL
day	NULL
after	NULL
transfection	NULL
with	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
,	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
TNF-	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
Genzyme	NULL
)	NULL
,	NULL
MG132	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
or	NULL
cyclosporine	NULL
A	NULL
(	NULL
0.5-5	NULL
ug/ml	NULL
;	NULL
Sandoz	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
another	NULL
24	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
repeated	NULL
at	NULL
least	NULL
four	NULL
times	NULL
with	NULL
different	NULL
plasmid	NULL
preparations	NULL
.	NULL

Chloram-phenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Reaction	NULL
mixtures	NULL
containing	NULL
25	NULL
ug	NULL
of	NULL
proteins	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h.	NULL
Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
luciferase	NULL
kit	NULL
obtained	NULL
from	NULL
Promega	NULL
.	NULL

Infection	NULL
and	NULL
p24	NULL
ELISA	NULL
assay	NULL
Jurkat	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
or	NULL
PBMC	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
proviral	NULL
genome	NULL
pNL4-3	NULL
.	NULL

After	NULL
2	NULL
h	NULL
,	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
or	NULL
TNF-	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
Genzyme	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Cell	NULL
culture	NULL
super-natants	NULL
were	NULL
harvested	NULL
every	NULL
24	NULL
h	NULL
,	NULL
free	NULL
virus	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
.	NULL

Virus	NULL
replication	NULL
in	NULL
culture	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
production	NULL
of	NULL
p24	NULL
protein	NULL
by	NULL
p24	NULL
viral	NULL
capsid	NULL
antigen	NULL
ELISA	NULL
(	NULL
Dupont	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
1	NULL
ng	NULL
of	NULL
*P	NULL
5'-end-labeled	NULL
KB	NULL
probe	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
10	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
25	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
12.5	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

Mixtures	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
protein-bound	NULL
DNA	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacryl-amide	NULL
gel	NULL
in	NULL
0.25x	NULL
TBE	NULL
(	NULL
1x	NULL
TBE	NULL
=	NULL
89	NULL
mM	NULL
Tris	NULL
,	NULL
89	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
unlabeled	NULL
KB	NULL
oligonucleotide	NULL
was	NULL
added	NULL
at	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
at	NULL
the	NULL
same	NULL
time	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

For	NULL
supershift	NULL
assays	NULL
,	NULL
antibodies	NULL
directed	NULL
against	NULL
NF-KBp50	NULL
(	NULL
sc-1190	NULL
)	NULL
specific	NULL
for	NULL
p50	NULL
and	NULL
p105	NULL
,	NULL
or	NULL
c-Rel	NULL
(	NULL
sc-272	NULL
)	NULL
reactive	NULL
with	NULL
both	NULL
c-Rel	NULL
p75	NULL
and	NULL
NF-KBp65	NULL
,	NULL
or	NULL
NF-AT	NULL
(	NULL
se-1149	NULL
)	NULL
reactive	NULL
with	NULL
NF-AT	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
C3	NULL
and	NULL
C4	NULL
,	NULL
or	NULL
Ets1/Ets2	NULL
(	NULL
sc-112	NULL
)	NULL
reactive	NULL
with	NULL
both	NULL
Ets	NULL
1	NULL
and	NULL
Ets2	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech-nology	NULL
)	NULL
,	NULL
or	NULL
normal	NULL
rabbit	NULL
serum	NULL
were	NULL
mixed	NULL
with	NULL
nuclear	NULL
proteins	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
prior	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
xB	NULL
synthetic	NULL
oligonucleotides	NULL
corresponds	NULL
to	NULL
the	NULL
-108/-77	NULL
sequence	NULL
of	NULL
the	NULL
HIV-1	NULL
(	NULL
LAI	NULL
)	NULL
LTR	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Jurkat	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
10	NULL
min	NULL
incubation	NULL
at	NULL
4°C	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
complemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
)	NULL
,	NULL
nuclei	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
collected	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Nuclear	NULL
pellets	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiotreitol	NULL
,	NULL
complemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
collected	NULL
by	NULL
a	NULL
2	NULL
min	NULL
centrifugation	NULL
at	NULL
10	NULL
000	NULL
r.p.m	NULL
.	NULL

and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

For	NULL
western	NULL
analysis	NULL
,	NULL
proteins	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
.	NULL

Membranes	NULL
were	NULL
preincubated	NULL
with	NULL
3	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
in	NULL
PBS	NULL
overnight	NULL
at	NULL
4°C	NULL
and	NULL
were	NULL
probed	NULL
with	NULL
polyclonal	NULL
antibodies	NULL
described	NULL
above	NULL
in	NULL
EMSA	NULL
(	NULL
1:5000	NULL
dilution	NULL
)	NULL
for	NULL
90	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
PBS-0.1	NULL
%	NULL
Tween	NULL
20	NULL
(	NULL
PBST	NULL
)	NULL
.	NULL

After	NULL
six	NULL
washes	NULL
with	NULL
PBST	NULL
for	NULL
5	NULL
min	NULL
,	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
peroxidase-labeled	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
1:7500	NULL
dilution	NULL
)	NULL
for	NULL
40	NULL
min	NULL
and	NULL
washed	NULL
six	NULL
times	NULL
for	NULL
5	NULL
min	NULL
in	NULL
PBST	NULL
.	NULL

The	NULL
signal	NULL
was	NULL
visualized	NULL
by	NULL
the	NULL
chemiluminescence	NULL
protocol	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

RESULTS	NULL
Dopamine	NULL
stimulates	NULL
HIV-1	NULL
transcription	NULL
and	NULL
replication	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
PBMC	NULL
To	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
dopamine	NULL
on	NULL
HIV-1	NULL
gene	NULL
transcrip-tion	NULL
,	NULL
the	NULL
LTR-CAT	NULL
reporter	NULL
vector	NULL
containing	NULL
the	NULL
full-length	NULL
LTR	NULL
of	NULL
the	NULL
HIV-1	NULL
LAI	NULL
strain	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
which	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
Fold	NULL
induction	NULL
to	NULL
T	NULL
dopamine	NULL
(	NULL
uM	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Dopamine	NULL
stimulates	NULL
HIV-1	NULL
LTR-driven	NULL
transcription	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
HIV-1	NULL
LTR-CAT	NULL
reporter	NULL
vector	NULL
and	NULL
cither	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dopamine	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
extracts	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
is	NULL
indicated	NULL
for	NULL
each	NULL
concentration	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
deviations	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

increasing	NULL
concentrations	NULL
of	NULL
dopamine	NULL
.	NULL

Analysis	NULL
of	NULL
CAT	NULL
activity	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
demonstrates	NULL
that	NULL
dopamine	NULL
is	NULL
able	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
up	NULL
to	NULL
3-	NULL
and	NULL
4-fold	NULL
with	NULL
100	NULL
and	NULL
300	NULL
LM	NULL
dopamine	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
dopamine	NULL
on	NULL
viral	NULL
replication	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
PBMC	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
proviral	NULL
clone	NULL
pNL	NULL
4-3	NULL
.	NULL

One	NULL
day	NULL
post-transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
100	NULL
LM	NULL
dopamine	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

HIV-1	NULL
replication	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cells	NULL
16	NULL
14	NULL
|	NULL
-e-	NULL
_-	NULL
#	NULL
-	NULL
#	NULL
-	NULL
dopamine	NULL
12	NULL
1	NULL
HIV-1	NULL
p24	NULL
protein	NULL
(	NULL
ng/	NULL
ml	NULL
)	NULL
0	NULL
24	NULL
48	NULL
72	NULL
96	NULL
post-stimulation	NULL
time	NULL
(	NULL
h	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
3293	NULL
culture	NULL
supernatant	NULL
was	NULL
monitored	NULL
every	NULL
24	NULL
h	NULL
over	NULL
a	NULL
4-day	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Results	NULL
show	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
dopamine	NULL
treatment	NULL
led	NULL
to	NULL
a	NULL
3-fold	NULL
enhancement	NULL
of	NULL
p24	NULL
antigen	NULL
levels	NULL
,	NULL
at	NULL
each	NULL
time	NULL
point	NULL
,	NULL
which	NULL
correlates	NULL
with	NULL
the	NULL
3-fold	NULL
increased	NULL
levels	NULL
of	NULL
HIV-1	NULL
transactivation	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
3-fold	NULL
enhancement	NULL
of	NULL
p24	NULL
levels	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
PBMC	NULL
,	NULL
at	NULL
time	NULL
points	NULL
posterior	NULL
to	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
NF-KB	NULL
element	NULL
is	NULL
involved	NULL
in	NULL
dopamine-induced	NULL
gene	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
in	NULL
neuronal	NULL
cells	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
is	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
COUP-TF	NULL
and	NULL
dopamine	NULL
through	NULL
the	NULL
-68/+29	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
LTR	NULL
(	NULL
12	NULL
)	NULL
.	NULL

To	NULL
delineate	NULL
the	NULL
LTR	NULL
sequences	NULL
responsible	NULL
for	NULL
dopamine-induced	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
transfected	NULL
LTR-CAT	NULL
vectors	NULL
containing	NULL
5°	NULL
deletions	NULL
of	NULL
the	NULL
LTR	NULL
region	NULL
and	NULL
tested	NULL
for	NULL
their	NULL
induction	NULL
following	NULL
dopamine	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
dopamine-induced	NULL
activation	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
deletion	NULL
of	NULL
sequences	NULL
upstream	NULL
of	NULL
position	NULL
-283	NULL
(	NULL
construct	NULL
2	NULL
)	NULL
;	NULL
deletion	NULL
of	NULL
the	NULL
NF-KB	NULL
binding	NULL
sites	NULL
up	NULL
to	NULL
position	NULL
-89	NULL
(	NULL
construct	NULL
3	NULL
)	NULL
dramatically	NULL
reduced	NULL
the	NULL
uninduced	NULL
expression	NULL
and	NULL
reduced	NULL
dopamine-induced	NULL
transcription	NULL
by	NULL
half	NULL
:	NULL
from	NULL
3.1	NULL
to	NULL
1.5	NULL
.	NULL

Further	NULL
removal	NULL
of	NULL
the	NULL
3	NULL
'	NULL
half	NULL
of	NULL
the	NULL
last	NULL
NF-KB	NULL
site	NULL
and	NULL
one	NULL
Sp1	NULL
site	NULL
up	NULL
to	NULL
position	NULL
-68	NULL
(	NULL
construct	NULL
4	NULL
)	NULL
or	NULL
all	NULL
three	NULL
Sp1	NULL
sites	NULL
up	NULL
to	NULL
position	NULL
-40	NULL
(	NULL
construct	NULL
5	NULL
)	NULL
completely	NULL
abolished	NULL
dopamine-induced	NULL
transcription	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
sequences	NULL
responsible	NULL
for	NULL
dopamine	NULL
induction	NULL
of	NULL
LTR-driven	NULL
transcription	NULL
are	NULL
contained	NULL
within	NULL
nucleotides	NULL
-283	NULL
to	NULL
-68	NULL
.	NULL

To	NULL
precisely	NULL
identify	NULL
the	NULL
proximal	NULL
promoter	NULL
elements	NULL
involved	NULL
in	NULL
dopamine	NULL
responsiveness	NULL
,	NULL
we	NULL
used	NULL
LTR-CAT	NULL
reporter	NULL
vectors	NULL
containing	NULL
internal	NULL
deletions	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
NF-KB	NULL
and	NULL
Spl	NULL
sites	NULL
within	NULL
the	NULL
-283/+80	NULL
LTR-CAT	NULL
(	NULL
construct	NULL
6	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
dopamine	NULL
induction	NULL
,	NULL
confirming	NULL
the	NULL
importance	NULL
of	NULL
these	NULL
sites	NULL
in	NULL
dopamine	NULL
responsiveness	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
two	NULL
NF-KB	NULL
binding	NULL
sites	NULL
(	NULL
construct	NULL
7	NULL
)	NULL
PBMC	NULL
3	NULL
-e-	NULL
0	NULL
.	NULL

-	NULL
#	NULL
-	NULL
dopamine	NULL
+	NULL
0	NULL
24	NULL
48	NULL
72	NULL
96	NULL
post-stimulation	NULL
time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
2	NULL
.	NULL

Dopamine	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
in	NULL
PBMC	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
proviral	NULL
clone	NULL
pNL4-3	NULL
.	NULL

After	NULL
24	NULL
h	NULL
they	NULL
were	NULL
treated	NULL
with	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
.	NULL

The	NULL
production	NULL
of	NULL
p24	NULL
antigen	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
evaluated	NULL
every	NULL
24	NULL
h.	NULL
For	NULL
each	NULL
time	NULL
point	NULL
,	NULL
p24	NULL
was	NULL
quantitated	NULL
in	NULL
triplicate	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
standard	NULL
error	NULL
did	NULL
not	NULL
exceed	NULL
15	NULL
%	NULL
.	NULL

3294	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
Relative	NULL
CAT	NULL
Activity	NULL
2	NULL
-283	NULL
E	NULL
[	NULL
1	NULL
(	NULL
1.7	NULL
HK	NULL
+	NULL
dopamine	NULL
Figure	NULL
3	NULL
.	NULL

NF-KB	NULL
sites	NULL
are	NULL
necessary	NULL
for	NULL
dopamine-induced	NULL
transcriptional	NULL
stimulation	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
LTR-CAT	NULL
constructs	NULL
used	NULL
in	NULL
transient	NULL
expression	NULL
assays	NULL
and	NULL
localization	NULL
of	NULL
some	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
NRRE	NULL
(	NULL
nuclear	NULL
receptor	NULL
responsive	NULL
element	NULL
)	NULL
,	NULL
NF-xB	NULL
,	NULL
Sp1	NULL
and	NULL
TATA	NULL
elements	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
LTR	NULL
region	NULL
of	NULL
the	NULL
LAI	NULL
HIV-1	NULL
strain	NULL
was	NULL
5-end-deleted	NULL
(	NULL
constructs	NULL
1-5	NULL
)	NULL
,	NULL
and	NULL
the	NULL
LTR	NULL
region	NULL
of	NULL
HxB2	NULL
was	NULL
internally	NULL
deleted	NULL
(	NULL
constructs	NULL
6-9	NULL
)	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
Relative	NULL
CAT	NULL
activities	NULL
in	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
LTR-CAT	NULL
constructs	NULL
,	NULL
either	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
100	NULL
uM	NULL
dopamine	NULL
for	NULL
24	NULL
h.	NULL
CAT	NULL
activities	NULL
are	NULL
expressed	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
construct	NULL
1	NULL
taken	NULL
as	NULL
1	NULL
.	NULL

The	NULL
standard	NULL
deviation	NULL
did	NULL
not	NULL
exceed	NULL
20	NULL
%	NULL
.	NULL

Numbers	NULL
in	NULL
brackets	NULL
indicate	NULL
the	NULL
fold	NULL
stimulation	NULL
induced	NULL
by	NULL
dopamine	NULL
.	NULL

or	NULL
the	NULL
three	NULL
Spl	NULL
sites	NULL
(	NULL
construct	NULL
8	NULL
)	NULL
decreased	NULL
the	NULL
induction	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
the	NULL
NF-KB	NULL
and	NULL
the	NULL
Spl	NULL
elements	NULL
in	NULL
dopamine-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

NF-KB	NULL
sites	NULL
are	NULL
sufficient	NULL
for	NULL
dopamine-induced	NULL
gene	NULL
transcription	NULL
To	NULL
precisely	NULL
examine	NULL
the	NULL
individual	NULL
role	NULL
of	NULL
NF-KB	NULL
and	NULL
Spl	NULL
sites	NULL
in	NULL
dopamine	NULL
responsiveness	NULL
,	NULL
we	NULL
used	NULL
constructs	NULL
containing	NULL
each	NULL
of	NULL
these	NULL
sites	NULL
in	NULL
a	NULL
heterologous	NULL
background	NULL
.	NULL

In	NULL
GC-WAP-CAT	NULL
and	NULL
NF-	NULL
«	NULL
B-WAP-CAT	NULL
,	NULL
the	NULL
-79/-45	NULL
Spl	NULL
sequences	NULL
or	NULL
the	NULL
-104/-79	NULL
sequence	NULL
containing	NULL
the	NULL
two	NULL
NF-KB	NULL
sites	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
respectively	NULL
,	NULL
are	NULL
inserted	NULL
in	NULL
front	NULL
of	NULL
the	NULL
whey	NULL
acidic	NULL
protein	NULL
(	NULL
WAP	NULL
)	NULL
promoter	NULL
containing	NULL
a	NULL
CAAT	NULL
box	NULL
and	NULL
a	NULL
TATA	NULL
box	NULL
(	NULL
23	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4	NULL
,	NULL
transcription	NULL
directed	NULL
by	NULL
the	NULL
Spl-containing	NULL
WAP	NULL
promoter	NULL
was	NULL
not	NULL
significantly	NULL
responsive	NULL
to	NULL
dopamine	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
with	NULL
NF-	NULL
«	NULL
B-WAP-CAT	NULL
,	NULL
dopamine	NULL
treatment	NULL
led	NULL
to	NULL
a	NULL
2.7-fold	NULL
stimulation	NULL
,	NULL
comparable	NULL
to	NULL
the	NULL
3.1-fold	NULL
induction	NULL
observed	NULL
with	NULL
HIV-1	NULL
LTR	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
xBmut-WAP-CAT	NULL
vector	NULL
,	NULL
which	NULL
contains	NULL
mutations	NULL
in	NULL
both	NULL
NF-KB	NULL
binding	NULL
sites	NULL
(	NULL
23	NULL
)	NULL
,	NULL
was	NULL
unable	NULL
to	NULL
cause	NULL
any	NULL
dopamine	NULL
responsiveness	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
NF-KB	NULL
sites	NULL
are	NULL
sufficient	NULL
to	NULL
mediate	NULL
dopamine-induced	NULL
gene	NULL
transcription	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Since	NULL
the	NULL
NF-KB	NULL
element	NULL
is	NULL
known	NULL
to	NULL
mediate	NULL
phorbol	NULL
ester	NULL
signaling	NULL
,	NULL
we	NULL
measured	NULL
as	NULL
a	NULL
control	NULL
the	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
caused	NULL
by	NULL
PMA	NULL
treatment	NULL
for	NULL
24	NULL
h.	NULL
Results	NULL
show	NULL
that	NULL
the	NULL
wild-type	NULL
©B-WAP	NULL
promoter	NULL
was	NULL
stimulated	NULL
68-fold	NULL
,	NULL
while	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
the	NULL
mutant	NULL
promoter	NULL
was	NULL
not	NULL
significantly	NULL
Relative	NULL
CAT	NULL
Activity	NULL
0	NULL
1°	NULL
2	NULL
3	NULL
60	NULL
70	NULL
Figure	NULL
4	NULL
.	NULL

NF-KB	NULL
sites	NULL
are	NULL
sufficient	NULL
for	NULL
dopamine-induced	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
GC-WAP-CAT	NULL
,	NULL
KB-WAP-CAT	NULL
and	NULL
xBmut-WAP-CAT	NULL
vectors	NULL
contain	NULL
the	NULL
-79/-45	NULL
three	NULL
Sp1	NULL
sites	NULL
,	NULL
the	NULL
-104/-79	NULL
wild-type	NULL
and	NULL
mutant	NULL
NF-xB	NULL
sequence	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
respectively	NULL
,	NULL
inserted	NULL
upstream	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
WAP	NULL
and	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
each	NULL
of	NULL
these	NULL
vectors	NULL
and	NULL
were	NULL
subsequently	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
either	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Relative	NULL
CAT	NULL
activities	NULL
are	NULL
represented	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
deviations	NULL
from	NULL
at	NULL
least	NULL
three	NULL
distinct	NULL
experiments	NULL
.	NULL

affected	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
HIV-1	NULL
LTR	NULL
was	NULL
stimulated	NULL
7.2-fold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
,	NULL
which	NULL
is	NULL
about	NULL
double	NULL
of	NULL
the	NULL
3.1-fold	NULL
dopamine-induced	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

An	NULL
inhibitor	NULL
of	NULL
proteasome	NULL
is	NULL
able	NULL
to	NULL
abolish	NULL
dopamine-induced	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
Activation	NULL
of	NULL
NF-KB	NULL
is	NULL
induced	NULL
by	NULL
pathways	NULL
which	NULL
are	NULL
controlled	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
complex	NULL
.	NULL

The	NULL
cytoplasmic	NULL
NF-KB	NULL
factor	NULL
,	NULL
complexed	NULL
to	NULL
the	NULL
IKB	NULL
inhibitor	NULL
,	NULL
is	NULL
translocated	NULL
in	NULL
the	NULL
nucleus	NULL
following	NULL
degradation	NULL
of	NULL
IKB	NULL
by	NULL
the	NULL
proteasome	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
active	NULL
NF-KB	NULL
dimers	NULL
are	NULL
generated	NULL
following	NULL
processing	NULL
of	NULL
p105	NULL
or	NULL
p100	NULL
into	NULL
p50	NULL
and	NULL
p52	NULL
proteins	NULL
by	NULL
the	NULL
proteasome	NULL
pathway	NULL
(	NULL
24,25	NULL
)	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
the	NULL
inhibitor	NULL
of	NULL
proteasome	NULL
MG132	NULL
prevents	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
and	NULL
thus	NULL
inhibits	NULL
NF-KB-mediated	NULL
LTR-driven	NULL
transcription	NULL
(	NULL
9,26,27	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
importance	NULL
of	NULL
NF-KB	NULL
in	NULL
dopamine	NULL
responsiveness	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
action	NULL
of	NULL
dopamine	NULL
was	NULL
repressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
HIV-1	NULL
LTR-CAT	NULL
or	NULL
xB-WAP-CAT	NULL
and	NULL
subsequently	NULL
treated	NULL
with	NULL
10	NULL
uM	NULL
of	NULL
MG132	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
dopamine	NULL
.	NULL

Results	NULL
indicate	NULL
that	NULL
treatment	NULL
with	NULL
MG132	NULL
alone	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
LTR-driven	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
decreased	NULL
xB-WAP-driven	NULL
transcription	NULL
by	NULL
half	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
the	NULL
PMA-induced	NULL
LTR-driven	NULL
stimulation	NULL
could	NULL
be	NULL
totally	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
uM	NULL
of	NULL
MG132	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dopamine	NULL
,	NULL
MG132	NULL
treatment	NULL
totally	NULL
suppressed	NULL
dopamine-induced	NULL
transcriptional	NULL
activation	NULL
of	NULL
both	NULL
LTR-CAT	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
and	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

We	NULL
controlled	NULL
by	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
treated	NULL
by	NULL
PMA	NULL
or	NULL
dopamine	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NF-KB	NULL
complexes	NULL
was	NULL
abolished	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
MG132	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
show	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
PMA-induced	NULL
activity	NULL
,	NULL
dopamine-induced	NULL
transcriptional	NULL
activity	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
which	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
action	NULL
of	NULL
dopamine	NULL
on	NULL
the	NULL
HIV-LTR	NULL
or	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
containing	NULL
KB	NULL
sites	NULL
requires	NULL
the	NULL
presence	NULL
of	NULL
NF-KB	NULL
proteins	NULL
.	NULL

Effect	NULL
of	NULL
dopamine	NULL
,	NULL
PMA	NULL
and	NULL
TNF-a	NULL
on	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
and	NULL
replication	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
in	NULL
PBMC	NULL
Besides	NULL
PMA	NULL
,	NULL
various	NULL
cytokines	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
via	NULL
NF-KB	NULL
(	NULL
25	NULL
)	NULL
.	NULL

TNF-	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
stimulate	NULL
LTR-driven	NULL
CAT	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
on	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
of	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
two	NULL
distinct	NULL
activators	NULL
of	NULL
NF-KB	NULL
,	NULL
Jurkat	NULL
cells	NULL
and	NULL
PBMC	NULL
were	NULL
transfected	NULL
with	NULL
LTR-CAT	NULL
and	NULL
LTR-Luc	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
subsequently	NULL
treated	NULL
with	NULL
either	NULL
dopamine	NULL
,	NULL
PMA	NULL
,	NULL
TNF-	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
two	NULL
signaling	NULL
molecules	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
dopamine	NULL
,	NULL
leading	NULL
each	NULL
to	NULL
a	NULL
3.1-	NULL
and	NULL
7.2-fold	NULL
activation	NULL
,	NULL
resulted	NULL
in	NULL
an	NULL
11.5-fold	NULL
stimulation	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
an	NULL
additive	NULL
effect	NULL
.	NULL

The	NULL
most	NULL
dramatic	NULL
effect	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
dopamine	NULL
and	NULL
TNF-	NULL
.	NULL

While	NULL
dopamine	NULL
and	NULL
TNF-	NULL
alone	NULL
led	NULL
to	NULL
a	NULL
3.1-	NULL
and	NULL
4.0-fold	NULL
increase	NULL
,	NULL
respectively	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
dopamine	NULL
and	NULL
TNF-	NULL
resulted	NULL
in	NULL
a	NULL
15-fold	NULL
synergistic	NULL
transcriptional	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
PBMC	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
TNF	NULL
and	NULL
dopamine	NULL
,	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
,	NULL
led	NULL
to	NULL
a	NULL
5.8-fold	NULL
transcriptional	NULL
increase	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
an	NULL
additive	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
combination	NULL
of	NULL
these	NULL
stimuli	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
HIV-1	NULL
in	NULL
PBMC	NULL
.	NULL

HIV-1	NULL
replication	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
was	NULL
monitored	NULL
over	NULL
a	NULL
5-day	NULL
period	NULL
,	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
3295	NULL
B	NULL
m	NULL
+MG132	NULL
Relative	NULL
CAT	NULL
activity	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
-	NULL
PMA	NULL
dop	NULL
-	NULL
dop	NULL
LTR-CAT	NULL
«	NULL
B-WAP	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
proteasome	NULL
inhibitor	NULL
MG132	NULL
inhibits	NULL
dopamine-induced	NULL
transcriptional	NULL
activation	NULL
driven	NULL
by	NULL
the	NULL
HIV-1	NULL
LTR	NULL
or	NULL
the	NULL
promoter	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
LTR-CAT	NULL
or	NULL
xB-WAP-CAT	NULL
and	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
MG132	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

Standard	NULL
deviations	NULL
did	NULL
not	NULL
exceed	NULL
20	NULL
%	NULL
.	NULL

following	NULL
treatment	NULL
with	NULL
combinations	NULL
of	NULL
the	NULL
various	NULL
stimuli	NULL
,	NULL
dopamine	NULL
,	NULL
PMA	NULL
or	NULL
TNF	NULL
.	NULL

In	NULL
Figure	NULL
6B	NULL
are	NULL
shown	NULL
the	NULL
results	NULL
obtained	NULL
5	NULL
days	NULL
after	NULL
infection	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
dopamine	NULL
and	NULL
PMA	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
dopamine	NULL
and	NULL
TNF	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
led	NULL
to	NULL
an	NULL
additive	NULL
increase	NULL
in	NULL
viral	NULL
replication	NULL
after	NULL
5	NULL
days	NULL
.	NULL

Since	NULL
the	NULL
PBMC	NULL
were	NULL
preactivated	NULL
with	NULL
PHA	NULL
,	NULL
it	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
PMA	NULL
treatment	NULL
failed	NULL
to	NULL
further	NULL
increase	NULL
HIV-1	NULL
replication	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
dopamine	NULL
responsiveness	NULL
was	NULL
mediated	NULL
through	NULL
a	NULL
calcium-dependent	NULL
and	NULL
,	NULL
more	NULL
specifically	NULL
,	NULL
a	NULL
calcineurin-dependent	NULL
pathway	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
LTR-CAT	NULL
and	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
dopamine	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
cyclosporine	NULL
A	NULL
(	NULL
0.5-8	NULL
ug/ml1	NULL
)	NULL
.	NULL

Cyclosporine	NULL
A	NULL
was	NULL
unable	NULL
to	NULL
affect	NULL
the	NULL
dopamine-induced	NULL
transcriptional	NULL
stimulation	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
dopamine	NULL
does	NULL
not	NULL
enhance	NULL
the	NULL
activity	NULL
of	NULL
calcineurin	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Dopamine	NULL
does	NULL
not	NULL
change	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
activities	NULL
and	NULL
NF-KB	NULL
levels	NULL
To	NULL
examine	NULL
whether	NULL
dopamine	NULL
treatment	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
xB	NULL
binding	NULL
activity	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
experiments	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
with	NULL
either	NULL
dopamine	NULL
or	NULL
PMA	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

It	NULL
was	NULL
reported	NULL
that	NULL
with	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
,	NULL
EMSA	NULL
analysis	NULL
displays	NULL
a	NULL
complex	NULL
pattern	NULL
of	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
can	NULL
be	NULL
affected	NULL
by	NULL
the	NULL
salt	NULL
concentration	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
and	NULL
the	NULL
conditions	NULL
of	NULL
cell	NULL
culture	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
PMA	NULL
treatment	NULL
caused	NULL
a	NULL
large	NULL
increase	NULL
of	NULL
two	NULL
DNA-protein	NULL
complexes	NULL
known	NULL
to	NULL
be	NULL
formed	NULL
by	NULL
NF-KB	NULL
proteins	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
.	NULL

As	NULL
3296	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
A	NULL
_	NULL
as	NULL
7	NULL
16	NULL
Jurkat	NULL
T	NULL
cells	NULL
6	NULL
PBMC	NULL
ed	NULL
3	NULL
>	NULL
14	NULL
Re	NULL
fe	NULL
12	NULL
3	NULL
3	NULL
10	NULL
#	NULL
0	NULL
+	NULL
g	NULL
[	NULL
x	NULL
<	NULL
8	NULL
#	NULL
03	NULL
U	NULL
9	NULL
3	NULL
%	NULL
¢	NULL
-	NULL
9	NULL
4	NULL
a	NULL
€	NULL
°	NULL
@	NULL
Cn	NULL
CJ	NULL
2	NULL
(	NULL
3	NULL
0	NULL
0	NULL
dop	NULL
PMA	NULL
_	NULL
PMA	NULL
_	NULL
TNFa	NULL
-	NULL
TNFc	NULL
dop	NULL
_	NULL
PMA	NULL
_	NULL
PMA	NULL
-	NULL
TNFa	NULL
-	NULL
TNFo-	NULL
PMA	NULL
-	NULL
PMA	NULL
dop	NULL
dop	NULL
dop	NULL
dop	NULL
TNFa	NULL
TNFa	NULL
dop	NULL
B	NULL
8	NULL
7	NULL
PBMC	NULL
é	NULL
6	NULL
&	NULL
ao	NULL
5	NULL
8	NULL
Po	NULL
4	NULL
-d	NULL
tt	NULL
4	NULL
.	NULL

3	NULL
>	NULL
2	NULL
A	NULL
i	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
dop	NULL
PMA	NULL
__	NULL
PMA	NULL
-	NULL
TNF	NULL
TNFo	NULL
_-	NULL
PMA	NULL
-	NULL
PMA	NULL
dop	NULL
dop	NULL
TNFa	NULL
-	NULL
TNFa	NULL
dop	NULL
Figure	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
dopamine	NULL
,	NULL
PMA	NULL
and	NULL
TNFQ	NULL
on	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
and	NULL
replication	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
cells	NULL
and	NULL
PBMC	NULL
were	NULL
transfected	NULL
with	NULL
LTR-CAT	NULL
and	NULL
LTR-Luc	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
subsequently	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
ng/m1	NULL
)	NULL
,	NULL
TNF-	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
dopamine	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Relative	NULL
CAT	NULL
and	NULL
luciferase	NULL
activities	NULL
are	NULL
represented	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
deviations	NULL
from	NULL
at	NULL
least	NULL
three	NULL
distinct	NULL
experiments	NULL
with	NULL
Jurkat	NULL
cells	NULL
and	NULL
two	NULL
experiments	NULL
with	NULL
PBMC	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
proviral	NULL
clone	NULL
pNL4-3	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
they	NULL
were	NULL
treated	NULL
with	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
!	NULL
)	NULL

,	NULL
TNE-	NULL
@	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
production	NULL
of	NULL
p24	NULL
antigen	NULL
in	NULL
the	NULL
supernatant	NULL
was	NULL
evaluated	NULL
every	NULL
24	NULL
h	NULL
for	NULL
5	NULL
days	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Only	NULL
the	NULL
time	NULL
point	NULL
after	NULL
5	NULL
days	NULL
is	NULL
shown	NULL
.	NULL

reported	NULL
previously	NULL
,	NULL
NF-KB	NULL
activity	NULL
comprises	NULL
a	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
which	NULL
,	NULL
in	NULL
PMA-stimulated	NULL
Jurkat	NULL
cells	NULL
,	NULL
give	NULL
rise	NULL
to	NULL
two	NULL
discrete	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
PMA	NULL
,	NULL
dopamine	NULL
treatment	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
minor	NULL
complex	NULL
C	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
,	NULL
of	NULL
electrophoretic	NULL
mobility	NULL
similar	NULL
to	NULL
the	NULL
faster	NULL
migrating	NULL
NF-KB	NULL
complex	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
complex	NULL
C	NULL
was	NULL
specific	NULL
,	NULL
since	NULL
it	NULL
was	NULL
competed	NULL
by	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
KB	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
xB	NULL
sequence	NULL
is	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
distinct	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
NF-KB/Re	NULL
!	NULL

l	NULL
family	NULL
and	NULL
the	NULL
zinc	NULL
finger	NULL
proteins	NULL
MBP1/PRII-BP1/HIV-EP1	NULL
and	NULL
MBP-2	NULL
(	NULL
31	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
complex	NULL
C	NULL
was	NULL
formed	NULL
by	NULL
proteins	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
,	NULL
we	NULL
performed	NULL
supershift	NULL
experiments	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
dopamine	NULL
for	NULL
4	NULL
h	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
either	NULL
NF-KBp50	NULL
,	NULL
or	NULL
p65	NULL
and	NULL
c-Rel	NULL
,	NULL
or	NULL
both	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
in	NULL
complex	NULL
C	NULL
was	NULL
demonstrated	NULL
,	NULL
since	NULL
addition	NULL
of	NULL
anti-p50	NULL
antibodies	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
,	NULL
but	NULL
not	NULL
a	NULL
non-immune	NULL
serum	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
anti-p65	NULL
antibodies	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
abolished	NULL
complex	NULL
C	NULL
formation	NULL
and	NULL
led	NULL
to	NULL
the	NULL
up-shifting	NULL
of	NULL
the	NULL
activity	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Since	NULL
interactions	NULL
between	NULL
Ets	NULL
and	NULL
NF-KB/NF-AT	NULL
proteins	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
regulate	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
32,33	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
supershift	NULL
experiments	NULL
with	NULL
antibodies	NULL
directed	NULL
against	NULL
NF-AT	NULL
(	NULL
C1-C4	NULL
)	NULL
and	NULL
Ets1/Ets2	NULL
.	NULL

Both	NULL
antibodies	NULL
were	NULL
unable	NULL
to	NULL
affect	NULL
complex	NULL
C	NULL
formation	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
complex	NULL
C	NULL
contains	NULL
only	NULL
NF-KBp5Q0	NULL
,	NULL
and	NULL
no	NULL
Ets	NULL
or	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Since	NULL
known	NULL
to	NULL
act	NULL
through	NULL
NF-KB	NULL
,	NULL
led	NULL
alone	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
dopamine	NULL
to	NULL
a	NULL
4.0-	NULL
and	NULL
15-fold	NULL
transcriptional	NULL
stimulation	NULL
,	NULL
respectively	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
EMSA	NULL
pattern	NULL
obtained	NULL
with	NULL
extracts	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
dopamine	NULL
,	NULL
TNF	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
signals	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
stimulation	NULL
with	NULL
TNF-q	NULL
led	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
major	NULL
NF-KB	NULL
complex	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
not	NULL
further	NULL
increased	NULL
upon	NULL
stimulation	NULL
with	NULL
dopamine	NULL
and	NULL
TNF	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
result	NULL
confirms	NULL
that	NULL
dopamine	NULL
does	NULL
not	NULL
induce	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
absence	NULL
of	NULL
NF-KB	NULL
translocation	NULL
induced	NULL
by	NULL
dopamine	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
levels	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
3297	NULL
A	NULL
PMA	NULL
dopamine	NULL
dopamine	NULL
C	NULL
treatment	NULL
(	NULL
h	NULL
)	NULL
0	NULL
10	NULL
2	NULL
4	NULL
8	NULL
0	NULL
1	NULL
2	NULL
4	NULL
8	NULL
Competitor	NULL
-	NULL
xB	NULL
-	NULL
-	NULL
-	NULL
>	NULL
dop	NULL
~	NULL
+	NULL
~	NULL
+	NULL
-	NULL
Antiserum	NULL
-	NULL
-	NULL
NIS	NULL
pS0	NULL
50	NULL
'	NULL
£50	NULL
pes	NULL
eso	NULL
TNFa	NULL
-	NULL
~	NULL
+	NULL
+	NULL
a	NULL
mnm	NULL
NF-xB	NULL
SC	NULL
ns	NULL
-	NULL
an	NULL
us	NULL
ad	NULL
d	NULL
us	NULL
i	NULL
ud	NULL
tnd	NULL
tnd	NULL
tnd	NULL
and	NULL
is	NULL
#	NULL
G	NULL
ths	NULL
dm	NULL
a	NULL
nso	NULL
-O	NULL
H0	NULL
ae	NULL
<	NULL
-	NULL
we	NULL
wa	NULL
)	NULL
#	NULL
mn	NULL
im	NULL
-U	NULL
HOBB	NULL
HEHE	NULL
co	NULL
ua	NULL
oa	NULL
i	NULL
©	NULL
a	NULL
.	NULL

to	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Figure	NULL
7	NULL
.	NULL

Dopamine	NULL
does	NULL
not	NULL
change	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
either	NULL
PMA	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
;	NULL
lanes	NULL
6-10	NULL
)	NULL
for	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
and	NULL
8	NULL
h.	NULL
The	NULL
NF-KB	NULL
complex	NULL
,	NULL
the	NULL
non-specific	NULL
complexes	NULL
(	NULL
ns	NULL
)	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Supershift	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
proteins	NULL
isolated	NULL
from	NULL
cells	NULL
treated	NULL
for	NULL
4	NULL
h	NULL
as	NULL
indicated	NULL
in	NULL
(	NULL
A	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
directed	NULL
against	NULL
NF-KB	NULL
p50	NULL
or	NULL
p65	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
or	NULL
non-immune	NULL
serum	NULL
(	NULL
NIS	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

A	NULL
competition	NULL
experiment	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
xB	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Complex	NULL
C	NULL
and	NULL
the	NULL
supershifted	NULL
complex	NULL
SC	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
dopamine	NULL
(	NULL
100	NULL
uM	NULL
)	NULL
and/or	NULL
TNF-	NULL
@	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

as	NULL
indicated	NULL
.	NULL

proteins	NULL
in	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
dopamine	NULL
over	NULL
a	NULL
2	NULL
h	NULL
period	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
revealed	NULL
that	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
IKB-	NULL
&	NULL
proteins	NULL
were	NULL
located	NULL
mostly	NULL
in	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
,	NULL
with	NULL
a	NULL
low	NULL
amount	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
.	NULL

Interestingly	NULL
,	NULL
protein	NULL
levels	NULL
were	NULL
unchanged	NULL
in	NULL
each	NULL
fraction	NULL
upon	NULL
dopamine	NULL
treatment	NULL
,	NULL
over	NULL
a	NULL
2	NULL
h	NULL
period	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
and	NULL
confirms	NULL
the	NULL
previous	NULL
observations	NULL
,	NULL
showing	NULL
unchanged	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Here	NULL
our	NULL
studies	NULL
reveal	NULL
that	NULL
the	NULL
neuromodulator	NULL
dopamine	NULL
can	NULL
contribute	NULL
,	NULL
by	NULL
itself	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cytokines	NULL
or	NULL
other	NULL
NF-KB	NULL
activating	NULL
agents	NULL
,	NULL
to	NULL
increase	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

In	NULL
the	NULL
endocrine	NULL
system	NULL
,	NULL
dopamine	NULL
is	NULL
synthesized	NULL
by	NULL
chromaffin	NULL
cells	NULL
present	NULL
in	NULL
the	NULL
adrenal	NULL
glands	NULL
,	NULL
and	NULL
is	NULL
secreted	NULL
into	NULL
blood	NULL
vessels	NULL
following	NULL
various	NULL
stimuli	NULL
,	NULL
especially	NULL
stress	NULL
conditions	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
T	NULL
lymphocytes	NULL
,	NULL
were	NULL
also	NULL
discovered	NULL
to	NULL
synthesize	NULL
,	NULL
transport	NULL
and	NULL
bind	NULL
catecholamines	NULL
,	NULL
such	NULL
as	NULL
dopamine	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

It	NULL
was	NULL
therefore	NULL
intriguing	NULL
to	NULL
test	NULL
whether	NULL
this	NULL
neuromodulator	NULL
,	NULL
whose	NULL
endocrine-mediated	NULL
secretion	NULL
in	NULL
the	NULL
immune	NULL
sytem	NULL
is	NULL
stress	NULL
dependent	NULL
,	NULL
affects	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
experiments	NULL
reveal	NULL
that	NULL
dopamine	NULL
is	NULL
able	NULL
to	NULL
stimulate	NULL
viral	NULL
replication	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
as	NULL
well	NULL
as	NULL
in	NULL
PBMC	NULL
,	NULL
which	NULL
correlates	NULL
with	NULL
increased	NULL
transactivation	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
show	NULL
that	NULL
dopamine	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
nuclei	NULL
cytoplasm	NULL
duration	NULL
of	NULL
treatment	NULL
o	NULL
30	NULL
60	NULL
90	NULL
0	NULL
30	NULL
60	NULL
so	NULL
__	NULL
mms	NULL
-S	NULL
treo	NULL
to	NULL
<	NULL
%	NULL
6	NULL
l	NULL
aug	NULL
“	NULL
(	NULL
pi	NULL
{	NULL
min	NULL
)	NULL
0	NULL
30	NULL
§0	NULL
120	NULL
0	NULL
30	NULL
60	NULL
120	NULL
fug	NULL
-a	NULL
p30	NULL
=	NULL
mn	NULL
mn	NULL
mgs	NULL
--	NULL
o_	NULL
(	NULL
min	NULL
)	NULL
0	NULL
30	NULL
60	NULL
120	NULL
Figure	NULL
8	NULL
.	NULL

Dopamine	NULL
does	NULL
not	NULL
change	NULL
NF-KB	NULL
levels	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
with	NULL
specific	NULL
antibodies	NULL
against	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
IxB-0	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
dopamine	NULL
for	NULL
various	NULL
times	NULL
,	NULL
ranging	NULL
from	NULL
O	NULL
to	NULL
120	NULL
min	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Specific	NULL
bands	NULL
for	NULL
p50	NULL
,	NULL
p65	NULL
and	NULL
IKB-	NULL
@	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

cytokine	NULL
TNF-Q	NULL
,	NULL
leads	NULL
to	NULL
a	NULL
synergistic	NULL
15-fold	NULL
transcriptional	NULL
stimulation	NULL
of	NULL
the	NULL
HIV-1	NULL
genome	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
to	NULL
an	NULL
additive	NULL
effect	NULL
in	NULL
PBMC	NULL
.	NULL

TNF-	NULL
is	NULL
known	NULL
as	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
HIV-1	NULL
transcription	NULL
and	NULL
replication	NULL
(	NULL
4,35	NULL
)	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
various	NULL
cytokines	NULL
,	NULL
including	NULL
TNF-Q	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
and	NULL
TGF-f	NULL
}	NULL
,	NULL
are	NULL
detected	NULL
in	NULL
the	NULL
sera	NULL
of	NULL
late	NULL
stage	NULL
disease	NULL
of	NULL
HIV-1-infected	NULL
patients	NULL
.	NULL

These	NULL
cytokines	NULL
stimulate	NULL
viral	NULL
replication	NULL
and	NULL
contribute	NULL
to	NULL
3298	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
HIV-1	NULL
pathogenesis	NULL
(	NULL
reviewed	NULL
in	NULL
26	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
reveal	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
dopamine	NULL
and	NULL
TNF-	NULL
is	NULL
a	NULL
potent	NULL
mediator	NULL
of	NULL
increased	NULL
HIV-1	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
further	NULL
demonstrate	NULL
that	NULL
dopamine	NULL
responsiveness	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
NF-KB	NULL
sites	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
.	NULL

A	NULL
minimal	NULL
xB-WAP	NULL
promoter	NULL
containing	NULL
two	NULL
KB	NULL
sites	NULL
,	NULL
but	NULL
not	NULL
a	NULL
mutated	NULL
xBmut-WAP	NULL
region	NULL
,	NULL
was	NULL
also	NULL
sufficient	NULL
for	NULL
dopamine-mediated	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
dopamine	NULL
represents	NULL
a	NULL
new	NULL
member	NULL
on	NULL
the	NULL
list	NULL
of	NULL
stimuli	NULL
which	NULL
are	NULL
©B-mediated	NULL
transcriptional	NULL
activators	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
NF-KB/Rel	NULL
family	NULL
contains	NULL
five	NULL
DNA-binding	NULL
members	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
p65/ReIA	NULL
,	NULL
c-Rel	NULL
and	NULL
RelB	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Our	NULL
supershift	NULL
results	NULL
indicate	NULL
that	NULL
p50	NULL
proteins	NULL
are	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
at	NULL
a	NULL
low	NULL
constitutive	NULL
level	NULL
,	NULL
and	NULL
bind	NULL
to	NULL
the	NULL
KB	NULL
DNA	NULL
site	NULL
.	NULL

Surprisingly	NULL
,	NULL
in	NULL
contrast	NULL
with	NULL
PMA	NULL
and	NULL
TNF-a	NULL
,	NULL
dopamine	NULL
treatment	NULL
did	NULL
not	NULL
change	NULL
NF-KB	NULL
binding	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
establish	NULL
that	NULL
dopamine-induced	NULL
LTR-driven	NULL
transcription	NULL
through	NULL
the	NULL
NF-KB	NULL
sites	NULL
does	NULL
not	NULL
require	NULL
modification	NULL
of	NULL
the	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

These	NULL
observations	NULL
correlate	NULL
with	NULL
our	NULL
western	NULL
blot	NULL
results	NULL
,	NULL
which	NULL
show	NULL
that	NULL
in	NULL
our	NULL
culture	NULL
conditions	NULL
,	NULL
Jurkat	NULL
cells	NULL
contain	NULL
a	NULL
small	NULL
nuclear	NULL
fraction	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
NF-KB	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
unaffected	NULL
by	NULL
dopamine	NULL
treatment	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
NF-KB	NULL
is	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
through	NULL
its	NULL
association	NULL
with	NULL
the	NULL
IKB	NULL
family	NULL
of	NULL
proteins	NULL
.	NULL

Cytosolic	NULL
IKB-	NULL
&	NULL
has	NULL
a	NULL
half-life	NULL
of	NULL
1-2	NULL
h	NULL
,	NULL
and	NULL
is	NULL
rapidly	NULL
degraded	NULL
upon	NULL
stimulation	NULL
by	NULL
activating	NULL
agents	NULL
such	NULL
as	NULL
phorbol	NULL
esters	NULL
,	NULL
IL-1	NULL
and	NULL
TNF-	NULL
(	NULL
26,36	NULL
)	NULL
.	NULL

We	NULL
show	NULL
that	NULL
IxB-a	NULL
levels	NULL
are	NULL
unaffected	NULL
by	NULL
dopamine	NULL
-	NULL
stimulation	NULL
,	NULL
confirming	NULL
that	NULL
dopamine	NULL
does	NULL
not	NULL
induce	NULL
NF-KB	NULL
nuclear	NULL
translocation	NULL
.	NULL

Taken	NULL
together	NULL
our	NULL
findings	NULL
reveal	NULL
a	NULL
mechanism	NULL
for	NULL
HIV-1	NULL
gene	NULL
activation	NULL
by	NULL
NF-KB	NULL
,	NULL
through	NULL
unchanged	NULL
DNA	NULL
binding	NULL
activities	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
recently	NULL
reported	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
upon	NULL
TGF-f	NULL
}	NULL
treatment	NULL
;	NULL
HaCaT	NULL
cells	NULL
contain	NULL
a	NULL
constitutive	NULL
fraction	NULL
of	NULL
NF-KB	NULL
proteins	NULL
in	NULL
the	NULL
nuclei	NULL
,	NULL
unaffected	NULL
by	NULL
TGF-fB	NULL
stimulation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
proteasome	NULL
pathway	NULL
for	NULL
NF-KB	NULL
activation	NULL
has	NULL
been	NULL
well	NULL
established	NULL
.	NULL

NF-KB	NULL
molecules	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
the	NULL
inhibitor	NULL
IKB	NULL
are	NULL
translocated	NULL
within	NULL
the	NULL
nuclei	NULL
following	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
formation	NULL
of	NULL
p50	NULL
is	NULL
generated	NULL
by	NULL
processing	NULL
of	NULL
the	NULL
N-terminal	NULL
portion	NULL
of	NULL
p105	NULL
by	NULL
a	NULL
proteasome-mediated	NULL
process	NULL
(	NULL
11,24,37	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
which	NULL
completely	NULL
clears	NULL
the	NULL
nuclei	NULL
from	NULL
all	NULL
NF-KB	NULL
molecules	NULL
,	NULL
totally	NULL
abolished	NULL
dopamine-induced	NULL
stimulation	NULL
.	NULL

This	NULL
repression	NULL
of	NULL
dopamine	NULL
responsiveness	NULL
by	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
suggests	NULL
that	NULL
the	NULL
fraction	NULL
of	NULL
NF-KB	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
is	NULL
both	NULL
sufficient	NULL
and	NULL
essential	NULL
to	NULL
mediate	NULL
dopamine	NULL
action	NULL
.	NULL

It	NULL
therefore	NULL
appears	NULL
that	NULL
dopamine	NULL
,	NULL
to	NULL
play	NULL
its	NULL
role	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
,	NULL
requires	NULL
the	NULL
action	NULL
of	NULL
another	NULL
stimulus	NULL
which	NULL
first	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
HIV-1	NULL
infected	NULL
T	NULL
cells	NULL
,	NULL
autocrine	NULL
secretion	NULL
of	NULL
TNF-	NULL
@	NULL
was	NULL
shown	NULL
to	NULL
control	NULL
HIV-1	NULL
replication	NULL
because	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
maintain	NULL
elevated	NULL
NF-KB	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
38	NULL
)	NULL
.	NULL

A	NULL
constitutive	NULL
NF-KB	NULL
activity	NULL
was	NULL
also	NULL
described	NULL
in	NULL
neurons	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Our	NULL
previous	NULL
results	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
neuronal	NULL
SK-N-MC	NULL
cells	NULL
,	NULL
dopamine	NULL
treatment	NULL
alone	NULL
is	NULL
unable	NULL
to	NULL
affect	NULL
HIV-1	NULL
transcription	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
dopamine	NULL
stimulates	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increased	NULL
levels	NULL
of	NULL
the	NULL
nuclear	NULL
receptor	NULL
COUP-TF	NULL
via	NULL
the	NULL
proximal	NULL
-68/+80	NULL
LTR	NULL
region	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
our	NULL
preliminary	NULL
data	NULL
indicate	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
dopamine	NULL
responsiveness	NULL
can	NULL
be	NULL
mediated	NULL
by	NULL
overexpressed	NULL
COUP-TF	NULL
and/or	NULL
CREB	NULL
proteins	NULL
via	NULL
the	NULL
proximal	NULL
-68/+80	NULL
LTR	NULL
region	NULL
.	NULL

These	NULL
data	NULL
reveal	NULL
a	NULL
variety	NULL
of	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
dopamine	NULL
modulates	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
.	NULL

Here	NULL
our	NULL
data	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
stress	NULL
the	NULL
fact	NULL
that	NULL
dopamine	NULL
alone	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
through	NULL
NF-KB	NULL
.	NULL

The	NULL
classic	NULL
NF-KB	NULL
activation	NULL
mechanism	NULL
,	NULL
triggered	NULL
by	NULL
a	NULL
number	NULL
of	NULL
extracellular	NULL
inducers	NULL
such	NULL
as	NULL
phorbol	NULL
esters	NULL
,	NULL
TNF-a	NULL
and	NULL
oxygen	NULL
peroxide	NULL
,	NULL
involves	NULL
activation	NULL
of	NULL
a	NULL
protein	NULL
kinase	NULL
that	NULL
phosphorylates	NULL
IxB	NULL
and	NULL
p105	NULL
,	NULL
followed	NULL
by	NULL
degradation	NULL
of	NULL
IxB	NULL
,	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
(	NULL
40,41	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
second	NULL
signaling	NULL
pathway	NULL
,	NULL
distinct	NULL
from	NULL
the	NULL
IKBa	NULL
degradation	NULL
and	NULL
NF-KB	NULL
nuclear	NULL
translocation	NULL
mechanism	NULL
.	NULL

Overexpression	NULL
of	NULL
p21	NULL
(	NULL
CIP1/WAF1	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
without	NULL
inducing	NULL
changes	NULL
in	NULL
NF-KB	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
42	NULL
)	NULL
.	NULL

TGF-B	NULL
was	NULL
found	NULL
to	NULL
activate	NULL
NF-KB	NULL
proteins	NULL
present	NULL
constitutively	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
HaCaT	NULL
cells	NULL
,	NULL
through	NULL
a	NULL
yet	NULL
unidentified	NULL
pathway	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
second	NULL
signaling	NULL
pathway	NULL
triggered	NULL
by	NULL
IL-1	NULL
and	NULL
TNF-o	NULL
which	NULL
confers	NULL
NF-KB	NULL
transcriptional	NULL
competency	NULL
was	NULL
identified	NULL
in	NULL
A549	NULL
epithelial	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Here	NULL
our	NULL
data	NULL
also	NULL
reveal	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
dopamine-induced	NULL
pathway	NULL
distinct	NULL
from	NULL
the	NULL
classic	NULL
NF-KB	NULL
activation	NULL
mechanism	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-KB	NULL
was	NULL
found	NULL
to	NULL
be	NULL
stimulated	NULL
through	NULL
phosphorylation	NULL
of	NULL
p65	NULL
by	NULL
PKA	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
phosphorylation	NULL
of	NULL
p50	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
a	NULL
key	NULL
step	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-KB	NULL
in	NULL
adenovirus	NULL
transformed	NULL
cells	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
scenario	NULL
involving	NULL
increased	NULL
phosphorylation	NULL
of	NULL
p50	NULL
induced	NULL
by	NULL
dopamine	NULL
signaling	NULL
may	NULL
explain	NULL
NF-KB	NULL
activation	NULL
by	NULL
dopamine	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
synergistic	NULL
effect	NULL
with	NULL
TNF-	NULL
.	NULL

Our	NULL
data	NULL
further	NULL
reveal	NULL
that	NULL
the	NULL
dopamine-mediated	NULL
effect	NULL
does	NULL
not	NULL
require	NULL
signaling	NULL
through	NULL
the	NULL
calcium-activated	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
which	NULL
activates	NULL
nuclear	NULL
import	NULL
of	NULL
NF-AT	NULL
transcription	NULL
factors	NULL
(	NULL
46,47	NULL
)	NULL
.	NULL

Clearly	NULL
,	NULL
further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
elucidate	NULL
the	NULL
precise	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
NF-KB	NULL
activation	NULL
by	NULL
dopamine	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
dopamine	NULL
signaling	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
will	NULL
also	NULL
be	NULL
interesting	NULL
to	NULL
examine	NULL
whether	NULL
the	NULL
action	NULL
of	NULL
dopamine	NULL
is	NULL
mediated	NULL
by	NULL
cellular	NULL
uptake	NULL
or	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
dopamine	NULL
receptors	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
We	NULL
thank	NULL
N.	NULL
Israél	NULL
for	NULL
providing	NULL
the	NULL
vector	NULL
containing	NULL
the	NULL
LTR	NULL
LAI	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
(	NULL
U338	NULL
)	NULL
,	NULL
the	NULL
Agence	NULL
Nationale	NULL
des	NULL
Recherches	NULL
sur	NULL
le	NULL
SIDA	NULL
,	NULL
the	NULL
Fondation	NULL
pour	NULL
la	NULL
Recherche	NULL
Medicale	NULL
(	NULL
FRM	NULL
)	NULL
,	NULL
the	NULL
association	NULL
'Le	NULL
Cercle	NULL
d'Emeraude	NULL
'	NULL
.	NULL

O.R	NULL
.	NULL

and	NULL
B.E.S	NULL
.	NULL

(	NULL
INSERM	NULL
U338	NULL
)	NULL
received	NULL
financial	NULL
support	NULL
from	NULL
FRM	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Garcia	NULL
,	NULL
J.A	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
R.B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
49	NULL
,	NULL
157-196	NULL
.	NULL

2	NULL
.	NULL

Kingsman	NULL
,	NULL
S.M	NULL
.	NULL

and	NULL
Kingsman	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
240	NULL
,	NULL
491-507	NULL
.	NULL

3	NULL
.	NULL

Tesmer	NULL
,	NULL
V.M	NULL
.	NULL

,	NULL
Rajadhyaksha	NULL
,	NULL
A.	NULL
,	NULL
Babin	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Bina	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
7298-7302	NULL
.	NULL

4	NULL
.	NULL

Osbomn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

5	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Ricber	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
2247-2258	NULL
.	NULL

6	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
Femandez	NULL
,	NULL
B.	NULL
,	NULL
Dominguez	NULL
,	NULL
L.	NULL
,	NULL
Jacque	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Thomas	NULL
,	NULL
D.	NULL
,	NULL
Diaz	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Moscat	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Virelizier	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
6596-6604	NULL
.	NULL

7	NULL
.	NULL

Li	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Shen	NULL
,	NULL
X.	NULL
,	NULL
Hu	NULL
,	NULL
P.P	NULL
.	NULL

and	NULL
Wang	NULL
,	NULL
X.F	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
18	NULL
,	NULL
110-121	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27.	NULL
.	NULL

Kretz-Remy	NULL
,	NULL
C.	NULL
,	NULL
Bates	NULL
,	NULL
E.E	NULL
.	NULL

and	NULL
Arrigo	NULL
,	NULL
A.P	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
3180-3191.	NULL
.	NULL

Baldwin	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
649-683	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
,	NULL
87	NULL
,	NULL
13-20	NULL
.	NULL

Thanos	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
,	NULL
80	NULL
,	NULL
529-532	NULL
.	NULL

Sawaya	NULL
,	NULL
B.E	NULL
.	NULL

,	NULL
Rohr,0	NULL
.	NULL

,	NULL
Aunis	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Schaeffer	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
23572-23576	NULL
.	NULL

Lin	NULL
,	NULL
C.W	NULL
.	NULL

,	NULL
Miller	NULL
,	NULL
Witte	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
Bianchi	NULL
,	NULL
B.R	NULL
.	NULL

,	NULL
Stashko	NULL
,	NULL
M.	NULL
,	NULL
Manelli	NULL
,	NULL
A.M.	NULL
and	NULL
Frail	NULL
,	NULL
D.E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

,	NULL
47	NULL
,	NULL
131-139	NULL
.	NULL

Mena	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Garcia	NULL
de	NULL
Yebenes	NULL
,	NULL
M.J.	NULL
,	NULL
Tabernero	NULL
,	NULL
C.	NULL
,	NULL
Casarejos	NULL
,	NULL
M.J.	NULL
,	NULL
Pardo	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Garcia	NULL
de	NULL
Yebenes	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Clin	NULL
.	NULL

Neuropharmacol	NULL
.	NULL

,	NULL
18	NULL
,	NULL
410-426	NULL
.	NULL

Van	NULL
den	NULL
Pol	NULL
,	NULL
A.N	NULL
.	NULL

,	NULL
Cao	NULL
,	NULL
V.	NULL
and	NULL
Belousov	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

Neurophysiol	NULL
.	NULL

,	NULL
76	NULL
,	NULL
3934-3948	NULL
.	NULL

Rogue	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Malviya	NULL
,	NULL
A.N	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
Signal	NULL
,	NULL
6	NULL
,	NULL
725-733	NULL
.	NULL

Bergquist	NULL
,	NULL
J.	NULL
,	NULL
Tarkowski	NULL
,	NULL
A.	NULL
,	NULL
Ekman	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Ewing	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
12912-12916	NULL
.	NULL

Faraj	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Olkowski	NULL
,	NULL
Z.L	NULL
.	NULL

and	NULL
Jackson	NULL
,	NULL
R.T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Pharmacology	NULL
,	NULL
48	NULL
,	NULL
320-327	NULL
.	NULL

Barili	NULL
,	NULL
P.	NULL
,	NULL
Bronzetti	NULL
,	NULL
E.	NULL
,	NULL
Felici	NULL
,	NULL
L.	NULL
,	NULL
Ferrante	NULL
,	NULL
F.	NULL
,	NULL
Ricci	NULL
,	NULL
A.	NULL
,	NULL
Zaccheo	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Amenta	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

Neuroimmunol	NULL
.	NULL

,	NULL
71	NULL
,	NULL
45-50	NULL
.	NULL

Ricci	NULL
,	NULL
A.	NULL
and	NULL
Amenta	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Neuroimmunol	NULL
.	NULL

,	NULL
53	NULL
,	NULL
1-7	NULL
.	NULL

Rohr,0	NULL
.	NULL

,	NULL
Aunis	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Schaeffer	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
,	NULL
31149-31155	NULL
.	NULL

Zeichner	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Kim	NULL
,	NULL
J.Y	NULL
.	NULL

and	NULL
Alwine	NULL
,	NULL
J.C	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
2436-2444	NULL
.	NULL

Taylor	NULL
,	NULL
J.P.	NULL
,	NULL
Pomerantz	NULL
,	NULL
R.	NULL
,	NULL
Bagasra,0	NULL
.	NULL

,	NULL
Chowdhury	NULL
,	NULL
M.	NULL
,	NULL
Rappaport	NULL
,	NULL
J.	NULL
,	NULL
Khalili	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Amini	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
11	NULL
,	NULL
3395-3403	NULL
.	NULL

Lin	NULL
,	NULL
L.	NULL
,	NULL
DeMartino	NULL
,	NULL
G.N	NULL
.	NULL

and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
,	NULL
92	NULL
,	NULL
819-828	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
Lin	NULL
,	NULL
R.	NULL
,	NULL
Beauparlant	NULL
,	NULL
P.	NULL
,	NULL
Wainberg	NULL
,	NULL
M	NULL
.	NULL

A.	NULL
and	NULL
Hiscott	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
59	NULL
,	NULL
481-505	NULL
.	NULL

Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
M.	NULL
,	NULL
Schmitt	NULL
,	NULL
M.J.	NULL
,	NULL
Hatanaka	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
12740-12744	NULL
.	NULL

Verma	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
Stevenson	NULL
,	NULL
J.K.	NULL
,	NULL
Schwarz	NULL
,	NULL
E.M.	NULL
,	NULL
Van	NULL
,	NULL
A.D.	NULL
and	NULL
Miyamoto	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
9	NULL
,	NULL
2723-2735	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1999	NULL
,	NULL
Vol	NULL
.	NULL

27	NULL
,	NULL
No	NULL
.	NULL

16	NULL
3299	NULL
Kubo	NULL
,	NULL
M.	NULL
,	NULL
Ohashi	NULL
,	NULL
T.	NULL
,	NULL
Fujii	NULL
,	NULL
M.	NULL
,	NULL
Oka	NULL
,	NULL
S.	NULL
,	NULL
Iwamoto	NULL
,	NULL
A.	NULL
,	NULL
Harada	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Kannagi	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
71	NULL
,	NULL
7560-7566	NULL
.	NULL

Perkins	NULL
,	NULL
Felzien	NULL
,	NULL
L.K	NULL
.	NULL

,	NULL
Betts	NULL
,	NULL
J.C.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Beach	NULL
,	NULL
D.H	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Science	NULL
,	NULL
275	NULL
,	NULL
523-527	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Walker	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D	NULL
.	NULL

W.	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
$	NULL
7	NULL
,	NULL
10028-10032	NULL
.	NULL

Seeler	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Muchardt	NULL
,	NULL
C.	NULL
,	NULL
Suessle	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Gaynor	NULL
,	NULL
(	NULL
1994	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
68	NULL
,	NULL
1002-1009	NULL
.	NULL

Bassuk	NULL
,	NULL
A.G.	NULL
,	NULL
Anandappa	NULL
,	NULL
R.T	NULL
.	NULL

and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
71	NULL
,	NULL
3563-3573	NULL
.	NULL

Macian	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
19	NULL
,	NULL
3645-3653	NULL
.	NULL

Aunis	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Inf	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

,	NULL
181	NULL
,	NULL
213-320	NULL
.	NULL

Duh	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
Maury	NULL
,	NULL
W.J	NULL
.	NULL

,	NULL
Folks	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Fauci	NULL
,	NULL
A.S.	NULL
and	NULL
Rabson	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
5974-5978	NULL
.	NULL

Sun	NULL
,	NULL
S.C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Ballard	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
,	NULL
259	NULL
,	NULL
1912-1915	NULL
.	NULL

Palombella	NULL
,	NULL
V.J	NULL
.	NULL

,	NULL
Rando,0.J	NULL
.	NULL

,	NULL
Goldberg	NULL
,	NULL
A.L	NULL
.	NULL

and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
,	NULL
78	NULL
,	NULL
773-785	NULL
.	NULL

Munoz	NULL
,	NULL
F.M	NULL
.	NULL

,	NULL
Navarro	NULL
,	NULL
J.	NULL
,	NULL
Garcia	NULL
,	NULL
A.	NULL
,	NULL
Punzon	NULL
,	NULL
C.	NULL
,	NULL
Fernandez	NULL
,	NULL
C.E	NULL
.	NULL

and	NULL
Fresno	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
100	NULL
,	NULL
838-845	NULL
.	NULL

Kaltschmidt	NULL
,	NULL
C.	NULL
,	NULL
Kaltschmidt	NULL
,	NULL
B.	NULL
,	NULL
Neumann	NULL
,	NULL
H.	NULL
,	NULL
Wekerle	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
3981-3992	NULL
.	NULL

Cheshire	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Baldwin	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
6746-6754	NULL
.	NULL

Traenckner	NULL
,	NULL
E.B.M	NULL
.	NULL

,	NULL
Wilk	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
5433-5441	NULL
.	NULL

Phares	NULL
,	NULL
W.	NULL
,	NULL
Franza	NULL
,	NULL
B.J	NULL
.	NULL

and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
7490-7498	NULL
.	NULL

Bergmann	NULL
,	NULL
M.	NULL
,	NULL
Hart	NULL
,	NULL
L.	NULL
,	NULL
Lindsay	NULL
,	NULL
M.	NULL
,	NULL
Barnes	NULL
,	NULL
P.J	NULL
.	NULL

and	NULL
Newton	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
273	NULL
,	NULL
6607-6610	NULL
.	NULL

Zhong	NULL
,	NULL
H.	NULL
,	NULL
SuYang	NULL
,	NULL
H.	NULL
,	NULL
Erdjument	NULL
,	NULL
B.H	NULL
.	NULL

,	NULL
Tempst	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Ghosh	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Cell	NULL
,	NULL
89	NULL
,	NULL
413-424	NULL
.	NULL

Kushner	NULL
,	NULL
D.B	NULL
.	NULL

and	NULL
Ricciardi	NULL
,	NULL
(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
19	NULL
,	NULL
2169-2179	NULL
.	NULL

Northrop.J.P	NULL
.	NULL

,	NULL
Ho	NULL
,	NULL
S.N	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
L.	NULL
,	NULL
Thomas	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
Timmermann	NULL
,	NULL
L.A.	NULL
,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Admon	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
,	NULL
369	NULL
,	NULL
497-502	NULL
.	NULL

Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Cell	NULL
,	NULL
96	NULL
,	NULL
611-614	NULL
.	NULL

